Chang Mark, Chow Shein-Chung, Pong Annpey
Millennium Pharmaceuticals Inc, Cambridge, MA 02139, USA.
J Biopharm Stat. 2006 May;16(3):299-309; discussion 311-2. doi: 10.1080/10543400600609718.
The issues and opportunities of adaptive designs are discussed. Starting with the definitions of an adaptive design, its validity and integrity are discussed. The three key components of an adaptive design, i.e., Type I error control, p-value adjustment, and unbiased estimation and confidence interval are addressed. Various seamless designs are investigated. Recommendations are made in the following aspects: study planning, trial monitoring, analysis and reporting, trial simulation, and regulatory perspectives.
讨论了适应性设计的问题与机遇。从适应性设计的定义出发,探讨了其有效性和完整性。阐述了适应性设计的三个关键组成部分,即I型错误控制、p值调整以及无偏估计和置信区间。研究了各种无缝设计。并在研究规划、试验监测、分析与报告、试验模拟以及监管角度等方面提出了建议。